Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 1, 2012, Pages 39-42

  Santayana, Elena M ^a,b   Grim, Shellee A ^a   Janda, William M ^a   Layden, Jennifer E ^a   Lee, Todd A ^a   Clark, Nina M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Enterococci; Intermediate susceptibility; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CORTICOSTEROID; CYCLOSPORIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; LINEZOLID; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; TACROLIMUS; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CANCER CHEMOTHERAPY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LENGTH OF STAY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS INFECTION;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VANCOMYCIN; YOUNG ADULT;

EID: 84865294901     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.05.025     Document Type: Article

References (11)

1. Bonora M.G., Ligozzi M., Luzzani A., Solbiati M., Stepan E., Fontana R. Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur J Clin Microbiol Infect Dis 2006, 25:197-198.
2. Bonora M.G., Solbiati M., Stepan E., Zorzi A., Luzzani A., Catania M.R., et al. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage. J Clin Microbiol 2006, 44:1153-1155.
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 21st informational supplement (M100-S21) 2011, CLSI, Wayne, PA.
4. Jones R.N., Della-Latta P., Lee L.V., Biedenbach D.J. Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2002, 42:137-139.
5. Kainer M.A., Devasia R.A., Jones T.F., Simmons B.P., Melton K., Chow S., et al. Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis 2007, 13:1024-1030.
6. Pai M.P., Rodvold K.A., Schreckenberger P.C., Gonzales R.D., Petrolatti J.M., Quinn J.P. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2002, 35:1269-1272.
7. Pogue J.M., Paterson D.L., Pasculle A.W., Potoski B.A. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2007, 28:1382-1388.
8. Rahim S., Pillai S.K., Gold H.S., Venkataraman L., Inglima K., Press R.A. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin Infect Dis 2003, 36:E146-E148.
9. Scheetz M.H., Knechtel S.A., Postelnick M.J., Malczynski M., Qi C. Differences in clinical outcomes in patients with vancomycin- resistant enterococci according to linezolid susceptibility. Pharmacother 2010, 30:1221-1228.
10. Seedat J., Zick G., Klare I., Konstabel C., Weiler N., Sahly H. Rapid emergence of resistance to linezolid during therapy of an Enterococcus faecium infection. Antimicrob Agents Chemother 2006, 50:4217-4219.
11. Swoboda S., Fritz S., Martignoni M.E., Feldhues R.A., Hoppe-Tichy T., Buchler M.W., et al. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report. J Antimicrob Chemother 2005, 56:787-789.